-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Aligos Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q2 2024.
- Aligos Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.06M, a 35.7% decline year-over-year.
- Aligos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14.7M, a 9.19% increase from 2021.
- Aligos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.5M, a 352% increase from 2020.
- Aligos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $2.98M, a 296% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)